Factors contributing to healthcare professional burnout during the COVID-19 pandemic: A rapid turnaround global survey LA Morgantini, U Naha, H Wang, S Francavilla, Ö Acar, JM Flores, ... PloS one 15 (9), e0238217, 2020 | 721 | 2020 |
STONE nephrolithometry: novel surgical classification system for kidney calculi Z Okhunov, JI Friedlander, AK George, BD Duty, DM Moreira, ... Urology 81 (6), 1154-1160, 2013 | 359 | 2013 |
A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies F Islami, DM Moreira, P Boffetta, SJ Freedland European urology 66 (6), 1054-1064, 2014 | 263 | 2014 |
Positive surgical margins increase risk of recurrence after partial nephrectomy for high risk renal tumors PH Shah, DM Moreira, Z Okhunov, VR Patel, S Chopra, AA Razmaria, ... The Journal of urology 196 (2), 327-334, 2016 | 193 | 2016 |
Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study AC Vidal, LE Howard, DM Moreira, R Castro-Santamaria, GL Andriole Jr, ... Cancer Epidemiology, Biomarkers & Prevention 23 (12), 2936-2942, 2014 | 175 | 2014 |
Evaluation and comparison of urolithiasis scoring systems used in percutaneous kidney stone surgery K Labadie, Z Okhunov, A Akhavein, DM Moreira, J Moreno-Palacios, ... The Journal of urology 193 (1), 154-159, 2015 | 172 | 2015 |
Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial RL Muller, L Gerber, DM Moreira, G Andriole, R Castro-Santamaria, ... European urology 62 (5), 757-764, 2012 | 160 | 2012 |
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group MJ Roobol, FH Schröder, J Hugosson, JS Jones, MW Kattan, EA Klein, ... World journal of urology 30, 149-155, 2012 | 135 | 2012 |
Cigarette smoking is associated with advanced renal cell carcinoma M Tsivian, DM Moreira, JR Caso, V Mouraviev, TJ Polascik Journal of clinical oncology 29 (15), 2027-2031, 2011 | 128 | 2011 |
Predicting time from metastasis to overall survival in castration-resistant prostate cancer: results from SEARCH DM Moreira, LE Howard, KN Sourbeer, HS Amarasekara, LC Chow, ... Clinical genitourinary cancer 15 (1), 60-66. e2, 2017 | 123 | 2017 |
Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study AC Vidal, LE Howard, DM Moreira, R Castro-Santamaria, GL Andriole, ... Clinical Cancer Research 21 (4), 756-762, 2015 | 122 | 2015 |
Prostate cancer risk in men with baseline history of coronary artery disease: results from the REDUCE Study JA Thomas, L Gerber, LL Bañez, DM Moreira, RS Rittmaster, GL Andriole, ... Cancer epidemiology, biomarkers & prevention 21 (4), 576-581, 2012 | 115 | 2012 |
The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group AJ Vickers, AM Cronin, MJ Roobol, J Hugosson, JS Jones, MW Kattan, ... Clinical Cancer Research 16 (17), 4374-4381, 2010 | 111 | 2010 |
Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration‐resistant prostate cancer, and mortality after radical … DM Moreira, WJ Aronson, MK Terris, CJ Kane, CL Amling, ... Cancer 120 (2), 197-204, 2014 | 108 | 2014 |
Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study J Jamnagerwalla, LE Howard, EH Allott, AC Vidal, DM Moreira, ... Prostate cancer and prostatic diseases 21 (2), 252-259, 2018 | 104 | 2018 |
Thresholds for PSA doubling time in men with non‐metastatic castration‐resistant prostate cancer LE Howard, DM Moreira, A De Hoedt, WJ Aronson, CJ Kane, CL Amling, ... BJU international 120 (5B), E80-E86, 2017 | 98 | 2017 |
Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study SJ Freedland, RJ Hamilton, L Gerber, LL Banez, DM Moreira, GL Andriole, ... Prostate cancer and prostatic diseases 16 (3), 254-259, 2013 | 93 | 2013 |
Chronic prostate inflammation is associated with severity and progression of benign prostatic hyperplasia, lower urinary tract symptoms and risk of acute urinary retention JC Nickel, CG Roehrborn, R Castro-Santamaria, SJ Freedland, ... The Journal of urology 196 (5), 1493-1498, 2016 | 90 | 2016 |
Partial nephrectomy is associated with higher risk of relapse compared with radical nephrectomy for clinical stage T1 renal cell carcinoma pathologically up staged to T3a PH Shah, DM Moreira, VR Patel, G Gaunay, AK George, M Alom, Z Kozel, ... The Journal of urology 198 (2), 289-296, 2017 | 87 | 2017 |
Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study DM Moreira, JC Nickel, L Gerber, RL Muller, GL Andriole, ... Cancer 120 (2), 190-196, 2014 | 87 | 2014 |